Ontology highlight
ABSTRACT: Importance
Hormone receptor-positive, ERBB2 (formerly HER2/neu)-negative metastatic breast cancer (HR-positive, ERBB2-negative MBC) is treated with targeted therapy, endocrine therapy, chemotherapy, or combinations of these modalities; however, evaluating the increasing number of treatment options is challenging because few regimens have been directly compared in randomized clinical trials (RCTs), and evidence has evolved over decades. Information theoretic network meta-analysis (IT-NMA) is a graph theory-based approach for regimen ranking that takes effect sizes and temporality of evidence into account.Objective
To examine the performance of an IT-NMA approach to rank HR-positive, ERBB2-negative MBC treatment regimens.Data sources
HemOnc.org, a freely available med
SUBMITTER: Li X
PROVIDER: S-EPMC9008500 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature